share

Ethyl [4-(4-Chlorophenyl)-2,4-Dimethyl-3,4-Dihydroquinolin-1(2H)-Yl](Oxo)Acetate CAS NO 1374509-57-5


Unit Price:

CAS No.:1374509-57-5

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Ethyl [4-(4-Chlorophenyl)-2,4-Dimethyl-3,4-Dihydroquinolin-1(2H)-Yl](Oxo)Acetate is a high-purity, advanced pharmaceutical intermediate with the CAS number 1374509-57-5. This compound is a critical building block in modern medicinal chemistry, valued for its complex heterocyclic structure that enables the synthesis of novel therapeutic agents. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) and anti-inflammatory targets.

Application

  • Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel quinoline-based drug candidates.
  • Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies for new therapeutic discovery.
  • API Development: Serves as a core scaffold in the development of potential APIs targeting neurological disorders.
  • Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and scale-up for clinical trial materials.
  • Chemical Reference Standard: Employed as an analytical standard for quality control and method development in pharmaceutical analysis.

Basic Information

Product Name Ethyl [4-(4-Chlorophenyl)-2,4-Dimethyl-3,4-Dihydroquinolin-1(2H)-Yl](Oxo)Acetate
CAS No. 1374509-57-5
Molecular Formula C21H22ClNO3
Molecular Weight 371.86 g/mol
Synonyms Ethyl 2-[4-(4-chlorophenyl)-2,4-dimethyl-3,4-dihydro-2H-quinolin-1-yl]-2-oxoacetate; 1,2,3,4-Tetrahydro-4-(4-chlorophenyl)-2,4-dimethyl-1-oxo-2-quinolineacetic Acid Ethyl Ester; Ethyl (4-(4-Chlorophenyl)-2,4-dimethyl-3,4-dihydroquinolin-1(2H)-yl)(oxo)acetate; 1374509-57-5; Quinoline-1-acetic acid derivative
EINECS Contact for details

Quality Control

Our Ethyl [4-(4-Chlorophenyl)-2,4-Dimethyl-3,4-Dihydroquinolin-1(2H)-Yl](Oxo)Acetate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from heat and incompatible materials. This product is light-sensitive (store away from light).

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Related Substances (HPLC) Any single impurity ≤ 0.5%, Total impurities ≤ 2.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.